Security key
22053A107
Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (QNCX)
CUSIP: 22053A107
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 7,677,996
- Total 13F value
- $11,976,762
- Share change
- +2,292,465
- Put/Call ratio
- 2.6%
- SEC-reported price per share
- $1.56
- Number of holders
- 41
- Value change
- +$3,808,602
- Number of buys
- 11
- Number of sells
- 20
- Shares outstanding
- 60,216,782
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
41
Top holders
10
QNCX full security history
Ownership snapshot
Full 13F holder table
IRulya Therapeutics Inc. SEC filings
IRulya Therapeutics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EPIQ Capital Group, LLC
Disclosed value leader
EPIQ Capital Group, LLC
Comparable rows
0/15
Latest evidence
31 Dec 2022
13F
3/4/5
Highest disclosed value: $673,216
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
EPIQ Capital Group, LLC has the largest disclosed position value at $673.2K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EPIQ Capital Group, LLC's linked filing trail.
Disclosed position value
Top 5
EPIQ Capital Group, LLC
$673.2K
VANGUARD GROUP INC
$544K
Philip S. Low
$488.1K
MILLENNIUM MANAGEMENT LLC
$380K
TWO SIGMA INVESTMENTS, LP
$297.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EPIQ Capital Group, LLC |
13F
Company
|
—
denominator unverified
|
$673,216
1,056,191 shares
|
— | 31 Dec 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$543,951
853,391 shares
|
— | 31 Dec 2022 |
| Philip S. Low |
3/4/5
Director
|
—
mixed-class rows
|
$488,126
541,341 shares
mixed-class rows
|
— | 19 May 2022 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$380,000
595,801 shares
|
— | 31 Dec 2022 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
—
denominator unverified
|
$297,847
467,284 shares
|
— | 31 Dec 2022 |
| TWO SIGMA ADVISERS, LP |
13F
Company
|
—
denominator unverified
|
$273,317
428,800 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
41
Shares
7,677,996
Rows available
41
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
41
Q1 2023 holders
41
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|